Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study

Target Oncol. 2020 Dec;15(6):801-802. doi: 10.1007/s11523-020-00773-3.

¹ Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy.
² Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
³ Medical Oncology Unit, IRCSS-IRST, Meldola, Italy.
⁴ Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy.
⁵ Medical Oncology Unit, University of Pisa, Pisa, Italy.
⁶ Medical Oncology Unit, San Benedetto del Tronto Hospital, ASUR Marche AV5, San Benedetto del Tronto, Italy.
⁷ International Center for T1D, Department of Biomedical and Clinical Sciences, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi "L. Sacco", University of Milan, Milan, Italy.
⁸ Oncology Department, Polytechnic University of Marche, Ancona, Italy.
⁹ Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.
¹⁰ Medical Oncology Unit, University of Modena, Modena, Italy.
¹¹ Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy. marioscartozzi@gmail.com.
¹² Oncologia Medica, Azienda Ospedaliera Universitaria Cagliari, Presidio Policlinico Universitario "Duilio Casula", Km 4500 Bivio per Sestu, S.S. 554, 09042, Monserrato, CA, Italy. marioscartozzi@gmail.com.

Abstract

The listing of the author names and affiliations, which previously read.